Search

Search Results
Results 2661 - 2670 of 8666 for Skin Cancer
  • Drug - 19 Aug 2026
    Consumer Medicine Information (CMI) about DBL Gemcitabine Injection intended for persons living in Australia.
  • News - 5 Aug 2026
    A comprehensive new review highlights the expanding importance of Lgr6, a member of the G protein-coupled receptor family, as a critical regulator of tissue homeostasis, injury repair, and disease...
  • Drug - 21 Jul 2026
    Consumer Medicine Information (CMI) about Norvir intended for persons living in Australia.
  • News - 11 Jun 2026
    Collagen, the protein that builds skin, bones, tendons and organs, exists inside cells as a liquid-like droplet rather than the long, rigid rod seen in textbooks over the last half century, according...
  • Drug - 30 Apr 2026
    Consumer Medicine Information (CMI) about Lazcluze intended for persons living in Australia.
  • News - 13 Mar 2026
    Findings indicate small increases in certain cancers linked to assisted reproduction, though overall cancer incidence aligns with the general female population.
  • News - 2 Mar 2026
    Researchers at The Jackson Laboratory (JAX), in collaboration with the Massachusetts Institute of Technology (MIT), have developed the first bandage-like microneedle patch that can sample the body's...
  • Drug - 17 Dec 2025
    Consumer Medicine Information (CMI) about Xelabine intended for persons living in Australia.
  • News - 15 Dec 2025
    In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor.
  • Drug - 10 Dec 2025
    Consumer Medicine Information (CMI) about Piqray intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.